Palisade Bio Inc. Gains 83.21%
Mon, Jan 29, 2024 at 07:16 PM
Palisade Bio Inc. (PALI:NASDAQ) rocketted at $0.96, representing a gain of 83.2%. On Mon, Jan 29, 2024, PALI:NASDAQ touched a New 2-Week High of $0.96. The stock got featured on our News Catalysts scanner on Mon, Jan 29, 2024 at 11:08 AM in the 'BIOTECH' category. From Tue, Jan 16, 2024, the stock recorded 33.33% Up Days and 30.00% Green Days
The stock spiked on Mon, Jan 29, 2024 at $1.49 with a volume of 134M+.
About Palisade Bio Inc. (PALI:NASDAQ)
Palisade Bio Inc is a late-stage biopharma company.
Top 10 Gainers:
- OneMedNet Corp. (ONMD:NASDAQ), 156.27%
- Palisade Bio Inc. (PALI:NASDAQ), 83.21%
- FibroGen, Inc. (FGEN:NASDAQ), 82.71%
- NexImmune Inc. (NEXI:NASDAQ), 73.83%
- Vinco Ventures Inc. (BBIG:NASDAQ), 55%
- Rail Vision Ltd. (RVSN:NASDAQ), 54.63%
- Connexa Sports Technologies Inc. (CNXA:NASDAQ), 43.69%
- View Inc. (VIEW:NASDAQ), 41.03%
- Selina Hospitality PLC (SLNA:NASDAQ), 38.04%
- Atreca, Inc. (BCEL:NASDAQ), 35.7%